2024
Why do older adults stop cancer screening? Findings from the Medicare Current Beneficiary Survey
Belliveau O, Richman I. Why do older adults stop cancer screening? Findings from the Medicare Current Beneficiary Survey. Journal Of The American Geriatrics Society 2024 PMID: 39444166, DOI: 10.1111/jgs.19239.Peer-Reviewed Original ResearchMedicare Current Beneficiary SurveyCancer screeningHealth statusScreening cessationPhysician recommendationBeneficiary SurveyEducational attainmentHistory of breast cancerBreast cancer screeningHigher educational attainmentNationally representative dataHistory of prostate cancerDiscontinue screeningScreening mammographyOlder adultsImprove communicationPatient preferencesWeighted populationPrimary outcomeRepresentative dataPhysiciansHealthProstate cancerBreast cancerMedicareACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update
Imaging P, Niell B, Jochelson M, Amir T, Brown A, Adamson M, Baron P, Bennett D, Chetlen A, Dayaratna S, Freer P, Ivansco L, Klein K, Malak S, Mehta T, Moy L, Neal C, Newell M, Richman I, Schonberg M, Small W, Ulaner G, Slanetz P. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update. Journal Of The American College Of Radiology 2024, 21: s126-s143. PMID: 38823941, DOI: 10.1016/j.jacr.2024.02.019.Peer-Reviewed Original ResearchConceptsReduce breast cancer mortalityRecommendation of mammographyBreast cancerBreast cancer mortalityBreast cancer riskBreast cancer screeningDigital breast tomosynthesisEvidence-based guidelinesAmerican College of Radiology Appropriateness CriteriaPeer-reviewed journalsMultidisciplinary expert panelRAND/UCLA Appropriateness Method User ManualMultiple different imaging modalitiesPeer-reviewed literatureScreening recommendationsCancer screeningCancer mortalityCancer riskGuideline developmentAppropriateness of imagingRecommendations AssessmentBreast tomosynthesisEstablished methodology principlesExpert panelAmerican College
2023
Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
Richman I, Long J, Soulos P, Wang S, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2023, 176: 1172-1180. PMID: 37549389, PMCID: PMC10623662, DOI: 10.7326/m23-0133.Peer-Reviewed Original ResearchConceptsCumulative incidenceBreast cancerBreast cancer screeningUnscreened womenOlder womenCancer screeningBreast cancer-specific deathBreast cancer overdiagnosisService Medicare claimsRetrospective cohort studyCancer-specific deathBreast cancer deathsWomen 70 yearsHarms of overdiagnosisNational Cancer InstituteBreast cancer diagnosisCohort studyCancer overdiagnosisCancer deathSEER programMedicare claimsCancer InstituteOverdiagnosisGreater incidenceCancer
2022
Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity
Richman I, Tessier-Sherman B, Galusha D, Oladele CR, Wang K. Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity. Journal Of The National Cancer Institute 2022, 115: 139-145. PMID: 36069622, PMCID: PMC9494402, DOI: 10.1093/jnci/djac172.Peer-Reviewed Original ResearchConceptsBreast cancer screeningCancer screeningHealth systemHealth equityBreast cancer controlRoutine health careCOVID-19 pandemicCOVID-19 waveMammography ratesCancer controlMammography useMultifactorial conditionHealth disparitiesWhite womenScreening mammographyHealth careWomenCOVID-19Subsequent COVID-19 wavesLower ratesNumber of studiesMammographyDisparitiesPandemicSpecific patterns
2021
Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old
Richman IB, Long JB, Hoag JR, Upneja A, Hooley R, Xu X, Kunst N, Aminawung JA, Kyanko KA, Busch SH, Gross CP. Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old. Journal Of The National Cancer Institute 2021, 113: 1515-1522. PMID: 33822120, PMCID: PMC8757313, DOI: 10.1093/jnci/djab063.Peer-Reviewed Original ResearchConceptsHigher cancer detection rateCancer detection rateBreast cancer screeningCancer screeningScreening outcomesBreast cancer screening outcomesDigital breast tomosynthesisCancer screening outcomesPopulation-level adoptionReal-world cohortMultivariable logistic regressionHigher biopsy ratesPatient-level analysisPopulation health impactDetection rateIncident cancerClinical outcomesWomen 40Biopsy rateObservational studyComparative effectivenessLogistic regressionYoung womenPrivate health insurersWomen
2020
Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance
Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Richman IB, Gross CP. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine 2020, 180: 799-801. PMID: 32202606, PMCID: PMC7147248, DOI: 10.1001/jamainternmed.2020.0262.Peer-Reviewed Original Research